FDA Inspection 1210000 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3003037054

The FDA completed an inspection of Novo Nordisk A/S on May 12, 2021 in Malov. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 12, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Malov (Denmark)

Additional Details

Mutual Recognition Agreement (MRA)